When do you implant a pacemaker in Myotonic Dystrophy?;Quand implanter un stimulateur cardiaque dans la maladie de Steinert ?

Presse Medicale

Volumn 40, Issue 7-8, 2011, Pages 748-753

  Babuty, Dominique ^a   Lallemand, Bénédicte ^a   Laurent, Valérie ^a   Clémenty, Nicolas ^a   Pierre, Bertrand ^a   Fauchier, Laurent ^a   Raynaud, Martine ^a   Pellieux, Sybille ^a  

^a UNIVERSITÉ DE TOURS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

MYOTONIC DYSTROPHY PROTEIN KINASE;

AGE DISTRIBUTION; ARTIFICIAL HEART PACEMAKER; ATRIOVENTRICULAR BLOCK; CLINICAL EVALUATION; DISEASE SEVERITY; ELECTROCARDIOGRAM; GENE MUTATION; HEART ELECTROPHYSIOLOGY; HEART VENTRICLE ARRHYTHMIA; HIGH RISK PATIENT; HUMAN; MYOTONIC DYSTROPHY; PATIENT SELECTION; RESPIRATORY FAILURE; SHORT SURVEY; SUDDEN DEATH; TREATMENT INDICATION; WEAKNESS;

ARRHYTHMIAS, CARDIAC; HUMANS; MYOTONIC DYSTROPHY; PACEMAKER, ARTIFICIAL; PATIENT SELECTION;

EID: 79959788024     PISSN: 07554982     EISSN: 07554982     Source Type: Journal    
DOI: 10.1016/j.lpm.2011.01.029     Document Type: Short Survey

References (33)

1. Lee J.E., Cooper T.A. Pathogenic mechanisms of myotonic dystrophy. Biochem Soc Trans 2009, 37:1281-1286.
2. Osborne R.J., Lin X., Welle S., et al. Transcriptional and post transcriptional impact of toxic RNA in myotonic dystrophy. Human Mol Gen 2009, 18:1471-1481.
3. De Die-Smulders C., Höweler C.J., Thijs C., et al. Age and causes of death in adult-onset myotonic dystrophy. Brain 1998, 121:1557-1563.
4. Phillips M.F., Harper P.S. Cardiac disease in myotonic dystrophy. Cardiovasc Res 1997, 33:13-22.
5. Groh W., Lowe M.R., Zipes D.P. Severity of cardiac conduction involvement and arrhythmias in myotonic dystrophy type 1 correlates with age and CTG repeat length. J Cardiovasc Electrophysiol 2002, 13:444-448.
6. Babuty D., Farrokhi T., Casset-Senon, et al. Cardiac condition in myotonic dystrophy. Eur Heart J 2002, 4(suppl):257.
7. Lazarus A., Varin J., Babuty D., Anselme F., Coste J., Duboc D. Long-term follow-up of arrhythmias in patients with myotonic dystrophy treated by pacing. A multicenter diagnosis pacemaker study. J Am Coll Cardiol 2002, 40:1645-1652.
8. Lazarus A., Varin J., Jauvert G., Alonso C., Duboc D. Relationship between cardiac arrhythmias and sleep apnea in permanently paced patients with type I myotonic dystrophy. Neuromuscular Dis 2007, 17:392-399.
9. Colleran J.A., Hawley R.J., Pinnow E.E., Kokkinos P.F., Fletcher R.D. Value of the electrocardiogram in determining cardiac events and mortality in myotonic dystrophy. Am J Cardiol 1997, 80:1494-1497.
10. Laurent V, Pellieux S, Corcia Ph et al. Mortality in myotonic dystrophy patients in the area of prophylactic pacing devices. Int J Cardiol 2010.
11. Merino J.L., Carmona J.R., Fernandez-Lozano I., Peinado R., Basterra N., Sobrino J.A. Mechanisms of sustained ventricular tachycardia in myotonic dystrophy. Implications for catheter ablation. Circulation 1998, 98:541-546.
12. Griggs R.C., Davis R.J., Anderson D.C., Dove J.T. Cardiac conduction in myotonic dystrophy. Am J Med 1975, 59:37-42.
13. Melacini P., Villanova C., Menegazzo E., et al. Correlations between involvement and CTG trinucleotide repeat length in myotonic dystrophy. J Am Coll Cardiol 1995, 25:239-245.
14. Olofsson B.O., Forsberg H., Andersson P.B., henriksson A., Wedin I. Electrocardiographic findings in myotonic dystrophy. B Heart J 1988, 59:47-52.
15. Florek R.C., Triffon D.W., Mann D.E., Ringel S.P., Reiter M.J. Electrocardiographic abnormalities in patients with myotonic dystrophy. West J Med 1990, 153:24-27.
16. Merlevede K, Vermander D, Theys P, Legius E, Ector H, Robberecht W. Cardiac involvement and CTG repeat expansion in myotonic dystrophy. J Neurol;249:693-698.
17. Lazarus A., Vain J., Ounnoughene Z., et al. Relationships among electrophysiological findings and clinical status, heart function, and extend of DNA mutation in myotonic dystrophy. Circulation 1999, 99:1041-1046.
18. Babuty D., Fauchier L., Tena-Carbi D., et al. Is it possible to identify infrahissian cardiac conduction abnormalities in myotonic dystrophy by non-invasive methods?. Heart 1999, 82:634-637.
19. Reardon W., Newcombe R., Fenton I., Sibert J., Harper P.S. The natural history of congenital myotonic dystrophy: mortality and long term clinical aspects. Arch Dis Child 1993, 68:177-181.
20. Komadja M., Frank R., Vedel J., Fontaine G., Petitot J.C., Grosgogeat Y. Intracardiac defects in dystrophia myotonica. B Heart J 1980, 43:315-320.
21. Hiromasa S., Ikeda T., Kubota K., et al. Myotonic dystrophy: ambulatory electrocardiogram, electrophysiologic study, and echocardiographic evaluation. Am Heart J 1987, 113:1482-1488.
22. Saba S., Vanderbrink B.A., Luciano B., et al. Localization of the sites of conduction abnormalities in a mouse model of myotonic dystrophy. J Cardiovasc Electrophysiol 1999, 10:1214-1220.
23. Berul C., Maguire C.T., Gehrmann J., Reddy S. Progressive atrioventricular conduction block in a mouse myotonic dystrophy model. J Interv Card Electrophysiol 2000, 4:351-358.
24. Nguyen H.H., Wolfe J.T., Homes D.R., Edwards W.D. Pathology of the cardiac conduction system in myotonic dystrophy: a study of 12 cases. J Am Coll Cardiol 1988, 11:662-671.
25. Babuty D., Fauchier L., Tena-Carbi D., et al. Significance of late ventricular potentials in myotonic dystrophy. Am J Cardiol 1999, 84:1099-1101.
26. Fragola P., Luzi M., Calo L., et al. Cardiac involvement in myotonic dystrophy. Am J Cardiol 1994, 74:1070-1072.
27. Mathieu J., Allard P., Potvin L., Begin P. A 10-year study of mortality in a cohort of patients with myotonic dystrophy. Neurology 1999, 52:1658-1662.
28. Nishioka S.A., Martinelli Filho M., Marie S., Zatz M., Costa R. Myotonic dystrophy and heart disease: behavior of arrhythmic events and conduction disturbances. Arq Bras Cardiol 2005, 84:330-336.
29. Groh W.J., Groh M., Saha C., et al. Electrocardiographic abnormalities and sudden death in myotonic dystrophytype 1. N Engl J Med 2008, 358:2688-2697.
30. Breton R., Mathieu J. Usefulness of clinical and electrocardiographic data for predicting adverse events in patients with myotonic dystrophy. Can J Cardiol 2009, 25:e23-e27.
31. Jouven X., Empana J.P., Swartz P.J., Desnos M., Courbon D., Ducimetiere P. Heart-rate profile during exercise as a predictor of sudden death. N Engl J Med 2005, 352:1951-1958.
32. ACC/AHA/HRS Guidelines device based therapy of cardiac rhythm abnormalities. J Am Coll Cardiol 2008; 51:1-62.
33. Russo D., Mangiola F., Della Bella P., et al. Risk of arrhythmias in myotonic dystrophy: trial design of the RAMYD study. J Cardiovasc Med 2009, 10:51-58.